Model
Edge
Vanda Pharmaceuticals
0001802653
Filing Type
4
Filing Date
11/17/2024
Updated
11/18/24, 3:45 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership